Portfolio (Quarterly)
Guide ↗
GENERAL ATLANTIC, L.P.
· CIK 0001017645| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XP | XP, INC | Financial Services | 20,566,133.0 | $391.6M | 18.23% | -2.1M | -9.4% | $19.04 | -7.1% |
| 2 | RVMD | REVOLUTION MEDICINES | Healthcare | 707,791.0 | $68.8M | 3.20% | -2.1M | -74.8% | $97.25 | +54.6% |
| 3 | NRIX | NURIX THERAPEUTICS | Healthcare | 4,101,865.0 | $63.6M | 2.96% | -795K | -16.2% | $15.50 | +13.1% |
| 4 | CNTA | CENTESSA PHARMACEUTICALS | Healthcare | 1,354,830.0 | $53.8M | 2.50% | -4.8M | -77.8% | $39.72 | +0.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
40.4%
Financial Services
36.8%
Healthcare
19.3%
Consumer Defensive
3.5%